{"id":"W2766006797","doi":"10.1016/j.jval.2017.08.2708","title":"Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Ixekizumab; Medicine; Dermatology Life Quality Index; Quality of life (healthcare); Ustekinumab; Internal medicine; Physical therapy; Placebo; Secukinumab; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003531041,0.0002352085,0.000975074,0.00009145885,0.0001298815,0.0004855148,0.0001524484,0.0003662383,0.004250101],"category_scores_gemma":[0.0005060073,0.00008455086,0.0007168084,0.00008953416,0.0002216003,0.0003960627,0.000165767,0.00135437,0.0003396423],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002336305,"about_ca_system_score_gemma":0.0003763221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000392809,"about_ca_topic_score_gemma":0.0006620819,"domain_scores_codex":[0.9998046,0.00004849719,0.00001285574,0.00002537461,0.00002161612,0.00008718486],"domain_scores_gemma":[0.9997086,0.0001086789,0.00004875471,0.00003022132,0.00001670606,0.00008704789],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4508812,0.01491134,0.01048611,0.0006319842,0.001007853,0.0003808792,0.0001061555,0.001116815,0.06957866,0.0007546053,0.005086128,0.4450582],"study_design_scores_gemma":[0.08620268,0.3674912,0.4113266,0.0004522855,0.00410533,0.002434958,0.0007005316,0.004682401,0.09722769,0.00324718,0.02199312,0.0001360121],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871535,0.007969533,0.0003079509,0.0008228282,0.0003788634,0.00003991047,0.0002060192,0.00004625971,0.00307518],"genre_scores_gemma":[0.9968206,0.001179595,0.0002321676,0.0001973511,0.0001126974,0.00001556625,0.0002135105,0.000004862307,0.001223674],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004250101,"threshold_uncertainty_score":0.01421803,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1093314165272608,"score_gpt":0.3473458678712141,"score_spread":0.2380144513439533,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}